BI Asset Management Fondsmaeglerselskab’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $773K | Buy |
14,071
+1,376
| +11% | +$75.6K | 0.01% | 538 |
|
|
2025
Q1 | $897K | Sell |
12,695
-15,366
| -55% | -$1.09M | 0.01% | 457 |
|
|
2024
Q4 | $1.84M | Buy |
28,061
+1,704
| +6% | +$112K | 0.02% | 378 |
|
|
2024
Q3 | $1.85M | Buy |
26,357
+24,187
| +1,115% | +$1.7M | 0.03% | 291 |
|
|
2024
Q2 | $179K | Sell |
2,170
-3,553
| -62% | -$293K | ﹤0.01% | 566 |
|
|
2024
Q1 | $500K | Sell |
5,723
-2,820
| -33% | -$246K | 0.01% | 529 |
|
|
2023
Q4 | $824K | Buy |
8,543
+5,434
| +175% | +$524K | 0.02% | 429 |
|
|
2023
Q3 | $275K | Hold |
3,109
| – | – | 0.01% | 582 |
|
|
2023
Q2 | $269K | Buy |
3,109
+1,759
| +130% | +$152K | 0.01% | 580 |
|
|
2023
Q1 | $131K | Sell |
1,350
-4,539
| -77% | -$440K | ﹤0.01% | 652 |
|
|
2022
Q4 | $609K | Buy |
5,889
+48
| +0.8% | +$4.96K | 0.02% | 394 |
|
|
2022
Q3 | $495K | Buy |
5,841
+951
| +19% | +$80.6K | 0.03% | 281 |
|
|
2022
Q2 | $405K | Hold |
4,890
| – | – | 0.02% | 339 |
|
|
2022
Q1 | $377K | Buy |
+4,890
| New | +$377K | 0.01% | 334 |
|
|
2020
Q4 | – | Sell |
-917
| Closed | -$70K | – | 388 |
|
|
2020
Q3 | $70K | Buy |
+917
| New | +$70K | ﹤0.01% | 425 |
|
|
2020
Q1 | – | Sell |
-1,551
| Closed | -$131K | – | 326 |
|
|
2019
Q4 | $131K | Sell |
1,551
-2,994
| -66% | -$253K | 0.01% | 301 |
|
|
2019
Q3 | $306K | Buy |
4,545
+1,042
| +30% | +$70.2K | 0.02% | 323 |
|
|
2019
Q2 | $300K | Buy |
+3,503
| New | +$300K | 0.01% | 206 |
|